ARCA biopharma, Inc.·4

Mar 3, 3:27 PM ET

SOBEL BURTON E 4

4 · ARCA biopharma, Inc. · Filed Mar 3, 2009

Insider Transaction Report

Form 4
Period: 2009-02-27
Transactions
  • Award

    Option to Purchase Common Stock

    2009-02-27+7,5007,500 total
    Exercise: $5.29Exp: 2019-02-27Common Stock (7,500 underlying)
Footnotes (1)
  • [F1]The options vest ratably on a monthly basis over a two year period; full acceleration upon change in control and termination of service.

Documents

2 files